https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Methods Mol. Biol. 2009;542:565-605
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Methods Mol. Biol. 2009;542:565-6052009-01-01 00:00:002021-11-15 17:03:01Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Klin Onkol 2009;22(2):67-72
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Klin Onkol 2009;22(2):67-722009-01-01 00:00:002019-02-15 08:50:58[The preparation of anticancer vaccine for patients with multiple myeloma on the base of monoclonal immunoglobulin loaded dendritic cells]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Folia Biol. (Praha) 2009;55(4):119-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Folia Biol. (Praha) 2009;55(4):119-252009-01-01 00:00:002019-02-15 08:53:16Dendritic cell-based immunotherapy induces transient clinical response in advanced rat fibrosarcoma – comparison with preventive anti-tumour vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-17 / Clin. Rheumatol. 2009 Apr;28(4):397-402
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-17 / Clin. Rheumatol. 2009 Apr;28(4):397-4022008-12-17 00:00:002019-02-15 09:17:37The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-13 / Cancer Immunol. Immunother. 2009 Dec;58(12):1935-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-13 / Cancer Immunol. Immunother. 2009 Dec;58(12):1935-92008-12-13 00:00:002008-12-13 00:00:00Mechanisms of murine dendritic cell antitumor dysfunction in aging
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-06 / Gynecol. Oncol. 2009 Feb;112(2):384-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-06 / Gynecol. Oncol. 2009 Feb;112(2):384-82008-12-06 00:00:002008-12-06 00:00:00Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer – a phase II study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-04 / Lung Cancer 2009 Jul;65(1):1-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-04 / Lung Cancer 2009 Jul;65(1):1-82008-12-04 00:00:002019-02-15 08:34:57Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-01 / Int J Hyperthermia 2008 Dec;24(8):649-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-01 / Int J Hyperthermia 2008 Dec;24(8):649-622008-12-01 00:00:002019-02-15 09:17:39Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-alpha: a description of a phase I-II protocol
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-11-28 / Cancer Lett. 2008 Nov;271(2):333-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-11-28 / Cancer Lett. 2008 Nov;271(2):333-412008-11-28 00:00:002019-02-15 09:16:51Vaccination with transforming growth factor-beta insensitive dendritic cells suppresses pulmonary metastases of renal carcinoma in mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-11-27 / Pigment Cell Melanoma Res 2009 Feb;22(1):30-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-11-27 / Pigment Cell Melanoma Res 2009 Feb;22(1):30-412008-11-27 00:00:002019-02-15 09:19:13Dendritic cells in the skin–potential use for melanoma treatment
